Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Gross Margin (2016 - 2025)

Marimed has reported Gross Margin over the past 15 years, most recently at 25.21% for Q4 2025.

  • Quarterly Gross Margin fell 728.0% to 25.21% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 36.28% through Dec 2025, down 350.0% year-over-year, with the annual reading at 36.22% for FY2025, 349.0% down from the prior year.
  • Gross Margin was 25.21% for Q4 2025 at Marimed, down from 40.14% in the prior quarter.
  • Over five years, Gross Margin peaked at 59.58% in Q2 2021 and troughed at 25.21% in Q4 2025.
  • The 5-year median for Gross Margin is 44.32% (2022), against an average of 44.58%.
  • The largest YoY upside for Gross Margin was 76bps in 2022 against a maximum downside of -1410bps in 2022.
  • A 5-year view of Gross Margin shows it stood at 49.9% in 2021, then decreased by -12bps to 44.13% in 2022, then rose by 1bps to 44.52% in 2023, then fell by -27bps to 32.49% in 2024, then dropped by -22bps to 25.21% in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Gross Margin are 25.21% (Q4 2025), 40.14% (Q3 2025), and 40.47% (Q2 2025).